HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiu Jie Wang Selected Research

Receptor Activity-Modifying Protein 3

3/2016Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiu Jie Wang Research Topics

Disease

1Chronic Renal Insufficiency
03/2016
1Vascular Calcification
03/2016

Drug/Important Bio-Agent (IBA)

1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
03/2016
1Cholecalciferol (Vitamin D3)FDA Link
03/2016
1Proteins (Proteins, Gene)FDA Link
03/2016
1Calcitonin Gene-Related PeptideIBA
03/2016
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
03/2016
1Calcitonin Receptors (Calcitonin Receptor)IBA
03/2016
1Receptor Activity-Modifying Protein 3IBA
03/2016

Therapy/Procedure

1Nephrectomy
03/2016